Related Experiment Video
Updated: Jun 29, 2026

In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease
Nasrin Yazdani1, Farzaneh Nejadian1, Nima Rezazadeh2
1Department of Otorhinolaryngology, Head and Neck Surgery, Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Despite some proposed roles for the diagnostic impact of the cervical vestibular evoked myogenic potential test in the patients with Meniere's disease, the role of this test as an objective instrument in following up the patients with Meniere's disease who underwent. Intratympanic steroid injection is not cleared. In a prospective study, thirty-one adult patients with definite one-sided Meniere's disease with vertigo as main complaint refractory to medical treatments for three months, were selected. Patients underwent three times of intratympanic dexamethasone injection with one-week intervals. We performed cervical vestibular evoked myogenic potential test at first and four weeks after the last injection for all participants. We followed the patients for one year. The study results were analyzed with the chi-square test. Cervical vestibular evoked myogenic potential test could not be recorded in 26 patients (83.9%), and the test results were abnormal in the remaining 5 patients. The results were abnormal in the healthy ear of 32.3% of the patients. Despite the clinical improvement of the symptoms after intratympanic injection, the test results were not changed. Cervical vestibular evoked myogenic potential test could not be recorded in the majority of the patients with Meniere's disease; while it is usually recorded in normal ears. On the other hand, results of the cervical vestibular evoked myogenic potential test do not change during the early phase after treatment and could not be a good option for follow up and evaluating the response in this situation.
Insights
The cervical vestibular evoked myogenic potential test is often unrecordable in Meniere's disease patients and doesn't change after intratympanic steroid injections, limiting its use for monitoring treatment response.
Area of Science:
- Otolaryngology
- Neuroscience
- Vestibular System
Background:
- Meniere's disease is a disorder of the inner ear.
- Intratympanic steroid injections are used to treat Meniere's disease.
- The diagnostic utility of cervical vestibular evoked myogenic potential (cVEMP) in Meniere's disease is debated, and its role in monitoring treatment response is unclear.
Purpose of the Study:
- To evaluate the role of the cervical vestibular evoked myogenic potential (cVEMP) test in monitoring patients with Meniere's disease after intratympanic steroid injections.
Main Methods:
- A prospective study included 31 adult patients with unilateral Meniere's disease refractory to medical treatment.
- Patients received three intratympanic dexamethasone injections at weekly intervals.
- The cVEMP test was performed before and four weeks after the last injection, with a one-year follow-up.
Main Results:
- cVEMP was unrecordable in 83.9% of Meniere's disease patients.
- Abnormal cVEMP results were found in 5 patients (16.1%), including the unaffected ear in 32.3% of cases.
- Despite clinical symptom improvement post-treatment, cVEMP results remained unchanged.
Conclusions:
- The cVEMP test is frequently unrecordable in Meniere's disease patients, unlike in healthy individuals.
- cVEMP results do not change in the early phase after intratympanic steroid treatment.
- The cVEMP test is not a suitable tool for follow-up or evaluating treatment response in Meniere's disease patients undergoing intratympanic steroid injections.
Related Concept Videos
The Vestibular System
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Equilibrium and Balance
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

